CHRIS CHESTERS

Senior HTA Adviser, NICE Medical Technologies Evaluation Programme (MTEP)

Chris is a Senior HTA Adviser in the NICE Medical Technologies Evaluation Programme (MTEP). He has over 10 years experience in roles across different programmes within NICE, and previously within a market access consultancy. He uses his insight and expertise in HTA and guidance development to ensure NICE is a world-leader in its approach to evaluating health technologies. He focuses on developing NICE’s methods and processes, and has particular interest in the evaluation of digital health technologies. Chris graduated with a Master’s degree in Biological Chemistry from the University of Sheffield and completed a PhD in Biochemistry from the University of Manchester.